三、文章
1.Effects of advanced glycosylation end products and rosiglitazone on the expression and secretion of galectin-3 in human renal mesangial cells. Chin Med J (Engl). 2009 May 5;122(9):1067-71. Sun ZL, Ma CJ, Jin H, Yuan Y, Liu NF.
2.Safety of an injection with a mixture of extracts from Herba Artemisiae annuae, Fructus Gardeniae and Flos Lonicerae.Pharm World Sci. 2009 Aug;31(4):458-63. Epub 2009 Apr 21. Xu HM, Wang Y, Liu NF.
3.Specific siRNA Targeting the Receptor for Advanced Glycation End Products Inhibits Experimental Hepatic Fibrosis in Rats. Int J Mol Sci. 2008 Apr;9(4):638-61. Epub 2008 Apr 24. Xia JR, Liu NF, Zhu NX.
4.[Therapeutic effects of magnetically labeled mononuclear and mesenchymal stem cells transplantation in a swine myocardial infarction model assessed by magnetic resonance imaging] Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Nov;36(11):1004-8. Qi CM, Ma GS, Liu NF, Chen Z, Shen CX, Liu XJ, Hu YP, Su YM, Li X, Zhang XL, Teng GJ, Ju SH.
www.lindalemus.com5.Effect of rosiglitazone on cardiac fibroblast proliferation, nitric oxide production and connective tissue growth factor expression induced by advanced glycation end-products. J Int Med Res. 2008 Mar-Apr;36(2):329-35. Li J, Liu NF, Wei Q.
6.Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model. Chin Med J (Engl). 2008 Mar 20;121(6):544-50. Qi CM, Ma GS, Liu NF, Shen CX, Chen Z, Liu XJ, Hu YP, Zhang XL, Teng GJ, Ju SH, Ma M, Tang YL
7.Identification and differentiation of magnetically labeled mesenchymal stem cells in vivo in swines with myocardial infarction. Int J Cardiol. 2009 Jan 24;131(3):417-9. Qi CM, Ma GS, Liu NF, Shen CX, Chen Z, Liu XJ, Hu YP, Zhang XL, Chen JY, Ju SH, Tang YL
8.[MR imaging of injected magnetically labeled stem cells in myocardial infarction: experiment with pigs] Zhonghua Yi Xue Za Zhi. 2007 Jun 12;87(22):1523-6. Qi CM, Ma GS, Liu NF, Chen Z, Shen CX, Liu XJ, Hu YP, Su YM, Li X, Teng GJ, Ju SH, Zhang XL, Gu N
上一页 [1] [2] [3] 下一页
